April A. N. Rose
- Oncology top 2%
- HER2/EGFR in Cancer Research 10
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 6
- Cancer Research top 10%
- Immunology and Allergy top 5%
- Immunology top 10%
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 16
-
- Lung Cancer Treatments and Mutations 7
-
- Synthesis and biological activity 5
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Cancer Mechanisms and Therapy 5
April A. N. Rose
52 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 998
- Cancer Research 307
- Immunology and Allergy 109
- Immunology 336
- Molecular Biology 958
Countries citing papers authored by April A. N. Rose
This map shows the geographic impact of April A. N. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April A. N. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April A. N. Rose more than expected).
Fields of papers citing papers by April A. N. Rose
This network shows the impact of papers produced by April A. N. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April A. N. Rose. The network helps show where April A. N. Rose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside April A. N. Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 19 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 26 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 0 | |
| 14 | 2018 | 47 | |
| 15 | 2015 | 96 | |
| 16 | 2013 | 68 | |
| 17 | 2010 | 157 | |
| 18 | 2010 | 168 | |
| 19 | 2010 | 21 | |
| 20 | Functional requirement for RGD and PKD domains of GPNMB in breast cancer metastasis | 2008 | 2 |
About April A. N. Rose
April A. N. Rose is a scholar working on Oncology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.9k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (16 papers), HER2/EGFR in Cancer Research (10 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Synthesis and biological activity (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer Mechanisms and Therapy (5 papers). The work is most often cited by research in Oncology (998 citations), Cancer Research (307 citations) and Immunology and Allergy (109 citations). April A. N. Rose has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Peter M. Siegel, Matthew Dankner, Ian R. Watson, Matthew G. Annis, Shivshankari Rajkumar, Michael Hallett, François Pépin, Caterina Russo, Zhifeng Dong and Morag Park. Their work appears in journals such as Journal of Clinical Oncology, Nature reviews. Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.